NCT02507960View on ClinicalTrials.gov

The Gamma Pod: A Clinical Feasibility Study Device GCC 1202: The Gamma Pod: A Clinical Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

August 9, 2018

Conditions
Breast Cancer
Interventions
DEVICE

The Gamma Pod

Immobilization of breast during radiation.

DEVICE

CT simulation

See arm description

Trial Locations (4)

21014

Upper Chesapeake Health, Bel Air

21044

Central Maryland Oncology Center, Columbia

21061

Baltimore Washington Medical Center, Glen Burnie

21201

Ummc Msgccc, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT02507960 - The Gamma Pod: A Clinical Feasibility Study Device GCC 1202: The Gamma Pod: A Clinical Feasibility Study | Biotech Hunter | Biotech Hunter